In the qubt stock forecast 2030 context, the company’s current partnerships with major cloud providers could be a strategic asset. Collaborative revenue models may enable stronger recurring income streams, influencing price-to-sales ratios positively. Relevance: Fundamentally, Eyenovia will be looking to create a modest niche within the massive ophthalmology industry. According to Data Bridge Market Research, the underlying global sector could expand at a CAGR of 6.4% from 2023 to 2030. At the forecast culmination, the valuation might hit nearly $84.66 billion. Last year, the industry was wroth $51.5 billion. And with Eyenovia only carrying a market cap of $78.3 million, it’s a tempting prospect. Is Quantum Computing the next multibagger AI stock? Read on to find out. For traders evaluating the qubt stock forecast 2030, current projections from sector reports suggest a compound annual growth rate (CAGR) above 30% for quantum solutions, a figure that could elevate QUBT’s market cap if commercialization milestones are met.
